| Literature DB >> 24904519 |
Valentina Parma1, Debora Zanatto1, Elisa Straulino1, Tomaso Scaravilli2, Umberto Castiello3.
Abstract
The performance of patients with vascular parkinsonism (VPD) on a reach-to-grasp task was compared with that of patients affected by idiopathic Parkinson's disease (IPD) and age-matched control subjects. The aim of the study was to determine how patients with VPD and IPD compare at the level of the kinematic organization of prehensile actions. We examined how subjects concurrently executed the transport and grasp components of reach-to-grasp movements when grasping differently sized objects. When comparing both VPD and IPD groups to control subjects, all patients showed longer movement duration and smaller hand opening, reflecting bradykinesia and hypometria, respectively. Furthermore, for all patients, the onset of the manipulation component was delayed with respect to the onset of the transport component. However, for patients with VPD this delay was significantly smaller than that found for the IPD group. It is proposed that this reflects a deficit - which is moderate for VPD as compared to IPD patients - in the simultaneous (or sequential) implementation of different segments of a complex movement. Altogether these findings suggest that kinematic analysis of reach-to-grasp movement has the ability to provide potential instruments to characterize different forms of parkinsonism.Entities:
Keywords: bradykinesia; hypometria; idiopathic Parkinson’s disease; kinematics; reach-to-grasp; vascular parkinsonism
Year: 2014 PMID: 24904519 PMCID: PMC4032884 DOI: 10.3389/fneur.2014.00075
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Demographic data and clinical features of the patients with vascular parkinsonism (VPD) studied.
| PD patient | Age (years) | Sex | Years since diagnosis | Most affected upper-limb | UPDRS (upper-limb) | UPSRR score | MMSE score | Clinical signs | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | R | B | A | P | O | F | ||||||||
| 1 | 66 | F | 3 | L | 4.4 | 35 | 30 | − | − | − | − | − | − | − |
| 2 | 68 | F | 3 | L | 3.3 | 37 | 30 | − | − | − | − | − | − | − |
| 3 | 68 | F | 2 | L | 6 | 31 | 30 | − | − | + | − | − | − | − |
| 4 | 69 | F | 4 | L | 4.8 | 34 | 30 | R | − | + | − | − | − | − |
| 5 | 69 | F | 1 | L | 3 | 33 | 29 | − | − | + | − | − | − | − |
| 6 | 70 | F | 3 | R | 8 | 36 | 29 | L | − | + | − | − | − | − |
| 7 | 72 | F | 2 | L | 3 | 35 | 28 | R | + | + | − | − | − | − |
| 8 | 68 | M | 2 | L | 6.2 | 32 | 29 | L | − | − | − | − | − | − |
| 9 | 66 | M | 4 | R | 5 | 36 | 30 | L | + | + | + | − | − | − |
| 10 | 67 | M | 2 | L | 10 | 34 | 29 | R | − | + | + | − | − | − |
| 11 | 69 | M | 3 | L | 4 | 37 | 30 | − | − | L | − | − | − | − |
| 12 | 71 | M | 2 | L | 8 | 35 | 30 | − | − | + | + | − | − | − |
Demographic data and clinical features of the patients with idiopathic Parkinson’s disease (IPD) studied.
| PD patient | Age (years) | Sex | Years since diagnosis | Stage of the disease | Most affected upper-limb | UPDRS (upper-limb) | UPSIT score | MMSE score | Dopaminergic medication | Clinical signs | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | R | B | A | P | O | F | ||||||||||
| 1 | 65 | F | 4 | II | L | 4 | 18 | 30 | 0–0–0 | − | + | + | − | − | − | − |
| 2 | 66 | F | 1 | II | L | 9 | 15 | 30 | 0.5–0.5–0.5b | − | − | + | + | − | − | − |
| 3 | 68 | F | 2 | II | R | 8 | 14 | 30 | 1–1–1a | − | − | + | + | − | − | − |
| 4 | 68 | F | 3 | I | R | 5 | 15 | 29 | 0–0–0 | − | − | R | L | − | − | − |
| 5 | 71 | F | 1 | I | R | 6 | 14 | 30 | 0–0–0 | − | + | R | − | − | − | − |
| 6 | 71 | F | 2 | II | L | 12 | 13 | 30 | 1–1–1 | R | R | + | + | − | − | − |
| 7 | 66 | M | 3 | II | L | 2 | 17 | 28 | 0–0–0 | − | − | + | + | − | − | − |
| 8 | 66 | M | 3 | II | L | 10 | 17 | 29 | 1–1–1a | − | + | R | + | − | − | − |
| 9 | 67 | M | 2 | II | L | 5 | 17 | 30 | 1–0–1a | − | + | + | + | − | − | − |
| 10 | 68 | M | 2 | I | L | 3 | 15 | 30 | 1–1–1a | R | + | + | + | − | − | − |
| 11 | 68 | M | 3 | I | L | 2 | 17 | 30 | 0–0–0 | − | − | R | − | − | − | − |
| 12 | 69 | M | 2 | I | R | 8 | 12 | 30 | 0–0–0 | − | − | + | − | − | − | − |
Medication: number of tablets, morning–midday–evening (dopaminergic medication, .
Figure 1Graphical representation of the experimental set-up. Legends indicate the relevant details.
Figure 2Visual presentation of the dependent variables measured for each of the groups tested. (A) Bar plot represents the movement duration expressed in milliseconds (ms). (B) Bar plot shows the maximum grip aperture measured in millimeters (mm). (C) Bar plot demonstrates the delay between the beginning of the arm movement towards the target object and the opening of the fingers to grasp it. VPD, vascular parkinsonism; IPD, idiopathic Parkinson’s disease; HC, healthy controls.